 |
Mack Roach III, MD
Recent Publications |
Publications – 2009 |
 |
Chung, H.T., P. Xia, L.W. Chan, E. Park-Somers,
and M. Roach, 3rd, Does image-guided radiotherapy improve
toxicity profile in whole pelvic-treated high-risk prostate
cancer? Comparison between IG-IMRT and IMRT. Int J Radiat
Oncol Biol Phys, 2009. 73(1): p. 53-60. |
|
Roach, M., 3rd, Predicting pathologic
stage, nomograms, and clinical judgment: don't miss the forest
for the trees! Int J Radiat Oncol Biol Phys, 2009. 73(2):
p. 325-6. |
|
Stone, N.N., L. Potters, B.J. Davis,
J.P. Ciezki, M.J. Zelefsky, M. Roach, K. Shinohara, P.A.
Fearn, M.W. Kattan, and R.G. Stock, Multicenter analysis
of effect of high biologic effective dose on biochemical
failure and survival outcomes in patients with Gleason score
7-10 prostate cancer treated with permanent prostate brachytherapy.
Int J Radiat Oncol Biol Phys, 2009. 73(2): p. 341-6. |
| |
Publications – 2008 |
|
Chan, L.W., P. Xia, A.R. Gottschalk,
M. Akazawa, M. Scala, B. Pickett, I.-C. Hsu, J. Speight,
and M. Roach, Proposed Rectal Dose for
Patients Undergoing Definitive Whole Pelvic Radiotherapy
for Clinically Localized Prostate Cancer. International Journal
of Radiation Oncology, Biology, Physics, 2008. |
|
D'Ambrosio, D.J., A. Pollack, E.E. Harris,
R.A. Price, Jr., L.J. Verhey, M. Roach, 3rd, D.J. Demanes,
M.L. Steinberg, L. Potters, P.E. Wallner, and A. Konski,
Assessment of external beam radiation technology for dose
escalation and normal tissue protection in the treatment
of prostate cancer. Int J Radiat Oncol Biol Phys, 2008. 70(3):
p. 671-7. |
|
Hartsell, W.F., M. Desilvio, D.W. Bruner,
C. Scarantino, R. Ivker, M. Roach, 3rd, J. Suh, W.F. Demas,
B. Movsas, I.A. Petersen, and A.A. Konski, Can physicians
accurately predict survival time in patients with metastatic
cancer? Analysis of RTOG 97-14. J Palliat Med, 2008. 11(5):
p. 723-8. |
|
Joseph, T., D.A. McKenna, A.C. Westphalen, F.V.
Coakley, S. Zhao, Y. Lu, I.C. Hsu, M. Roach, 3rd, and J.
Kurhanewicz, Pretreatment Endorectal Magnetic Resonance Imaging and Magnetic
Resonance Spectroscopic Imaging Features of Prostate Cancer as Predictors
of Response to External Beam Radiotherapy. Int J Radiat Oncol Biol Phys,
2008. |
|
Lawton, C.A., J. Michalski, I. El-Naqa,
D. Kuban, W.R. Lee, S.A. Rosenthal, A. Zietman, H. Sandler,
W. Shipley, M. Ritter, R. Valicenti, C. Catton, M. Roach,
3rd, T.M. Pisansky, and M. Seider, Variation in the Definition
of Clinical Target Volumes for Pelvic Nodal Conformal Radiation
Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys,
2008. |
|
Lometti, M.W., D. Thurston, M. Aubin, A. Bock, L. Verhey,
J.M. Lockhart, R. Bland, J. Pouliot, and M. Roach, 3rd, Are
lateral electronic portal images adequate for accurate on-line
daily targeting of the prostate? Results of a prospective
study. Med Dosim, 2008. 33(1): p. 22-9. |
|
McKenna, D.A., F.V. Coakley, A.C. Westphalen, S. Zhao,
Y. Lu, E.M. Webb, B. Pickett, M. Roach, 3rd, and J. Kurhanewicz,
Prostate Cancer: Role of Pretreatment MR in Predicting Outcome
after External-Beam Radiation Therapy--Initial Experience.
Radiology, 2008. |
|
Roach, M., 3rd, Editorial comment on: high provider
volume is associated with lower rate of secondary therapies
after definitive radiotherapy for localized prostate cancer. Eur Urol,
2008. 54(1): p. 105-6. |
|
Roach, M., 3rd, "Short- and long-term
mortality with localized prostate cancer": errors and
omissions? Arch Intern Med, 2008. 168(12): p. 1351; author
reply 1353. |
|
Roach, M., 3rd, Targeting pelvic lymph
nodes in men with intermediate- and high-risk prostate cancer,
and confusion about the results of the randomized trials.
J Clin Oncol, 2008. 26(22): p. 3816-7; author reply 3817-8. |
|
Roach, M., 3rd, K. Bae, J. Speight, H.B. Wolkov, P. Rubin,
R.J. Lee, C. Lawton, R. Valicenti, D. Grignon, and M.V. Pilepich,
Short-term neoadjuvant androgen deprivation therapy and external-beam
radiotherapy for locally advanced prostate cancer: long-term
results of RTOG 8610. J Clin Oncol, 2008. 26(4): p. 585-91. |
|
Roach, M., H. Chung, and J.L. Speight,
Intermediate-risk and Locally Advanced Prostate Cancer, in
Principles and Practice of Radiation Oncology, E. Halperin,
C. Perez, and L. Brady, Editors. 2008, Lippincott, Williams
and Wilkins. |
|
Sahgal, A., S. Jabbari, J. Chen, B.
Pickett, M. Roach, 3rd, V. Weinberg, I.C. Hsu, and J. Pouliot,
Comparison of dosimetric and biologic effective dose parameters
for prostate and urethra using 131 Cs and 125 I for prostate
permanent implant brachytherapy. Int J Radiat Oncol Biol
Phys, 2008. 72(1): p. 247-54. |
|
Schroder, F.H., M. Roach, 3rd, and
P. Scardino, Clinical decisions. Management of prostate cancer.
N Engl J Med, 2008. 359(24): p. 2605-9. |
|
Shinohara, K. and M. Roach, 3rd, Technique for Implantation
of Fiducial Markers in the Prostate. Urology, 2008. 71(2):
p. 196-200. |
|
Taussky, D., K. Bae, J.P. Bahary, M. Roach, 3rd, C.A.
Lawton, W.U. Shipley, and H.M. Sandler, Does Timing of Androgen
Deprivation Influence Radiation-Induced Toxicity? A Secondary
Analysis of Radiation Therapy Oncology Group Protocol 9413.
Urology, 2008. |
|
Yu, J.S. and M. Roach, 3rd, Quality of life and
satisfaction with outcome among prostate-cancer survivors.
N Engl J Med, 2008. 359(2): p. 200; author reply 201-2. |
| |
Publications – 2007 |
|
Bermudez, R.S., A. Izaguirre, and M. Roach,
3rd, State-of-the-art radiotherapy in the management of clinically
localized prostate carcinoma. Future Oncol, 2007. 3(1): p.
103-11. |
|
Frank, S.J., P.D. Grimm, J.E. Sylvester,
G.S. Merrick, B.J. Davis, A. Zietman, B.J. Moran, D.C. Beyer,
M. Roach, 3rd, D.H. Clarke, R.G. Stock, W. Robert Lee, J.M.
Michalski, K.E. Wallner, M. Hurwitz, L. Potters, D.A. Kuban,
B.R. Prestidge, R. Vera, S. Hathaway, and J.C. Blasko, Interstitial
implant alone or in combination with external beam radiation
therapy for intermediate-risk prostate cancer: a survey of
practice patterns in the United States. Brachytherapy, 2007.
6(1): p. 2-8. |
|
Lawton, C.A., M. Desilvio, M. Roach, 3rd,
V. Uhl, R. Kirsch, M. Seider, M. Rotman, C. Jones, S. Asbell,
R. Valicenti, S. Hahn, and C.R. Thomas, Jr., An Update of
the Phase III Trial Comparing Whole Pelvic to Prostate Only
Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression:
Updated Analysis of RTOG 94-13, with Emphasis on Unexpected
Hormone/Radiation Interactions. Int J Radiat Oncol Biol Phys,
2007. |
|
Lawton, C.A., M. DeSilvio, M. Roach, 3rd,
V. Uhl, R. Kirsch, M. Seider, M. Rotman, C. Jones, S. Asbell,
R. Valicenti, S. Hahn, and C.R. Thomas, Jr., An update of
the phase III trial comparing whole pelvic to prostate only
radiotherapy and neoadjuvant to adjuvant total androgen suppression:
updated analysis of RTOG 94-13, with emphasis on unexpected
hormone/radiation interactions. Int J Radiat Oncol Biol Phys,
2007. 69(3): p. 646-55. |
|
Lee, B., K. Shinohara, V. Weinberg, A.R.
Gottschalk, J. Pouliot, M. Roach, 3rd, and I.C. Hsu, Feasibility
of high-dose-rate brachytherapy salvage for local prostate
cancer recurrence after radiotherapy: the University of California-San
Francisco experience. Int J Radiat Oncol Biol Phys, 2007.
67(4): p. 1106-12. |
|
Litzenberg, D.W., T.R. Willoughby, J.M.
Balter, H.M. Sandler, J. Wei, P.A. Kupelian, A.A. Cunningham,
A. Bock, M. Aubin, M. Roach, 3rd, K. Shinohara, and J. Pouliot,
Positional Stability of Electromagnetic Transponders Used
for Prostate Localization and Continuous, Real-Time Tracking.
Int J Radiat Oncol Biol Phys, 2007. |
|
Ludlum, E., G. Mu, V. Weinberg, M. Roach, 3rd, L.J. Verhey,
and P. Xia, An algorithm for shifting MLC shapes to adjust
for daily prostate movement during concurrent treatment with
pelvic lymph nodes. Med Phys, 2007. 34(12): p. 4750-6. |
|
Meyer, J.L., S. Leibel, M. Roach, and S. Vijayakumar,
New technologies for the radiotherapy of prostate cancer.
A discussion of clinical treatment programs. Front Radiat
Ther Oncol, 2007. 40: p. 315-37. |
|
Mohler, J., R.J. Babaian, R.R. Bahnson, B. Boston, A.
D'Amico, J.A. Eastham, R.J. Hauke, R.P. Huben, P. Kantoff,
M. Kawachi, M. Kuettel, P.H. Lange, C. Logothetis, G. MacVicar,
A. Pollack, J.M. Pow-Sang, M. Roach, 3rd, H. Sandler, D.
Shrieve, S. Srinivas, P. Twardowski, D.A. Urban, and P.C.
Walsh, Prostate cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw, 2007. 5(7): p. 650-83. |
|
Roach, M., 3rd, Dose escalated external beam radiotherapy
versus neoadjuvant androgen deprivation therapy and conventional
dose external beam radiotherapy for clinically localized
prostate cancer: do we need both? Strahlenther Onkol, 2007.
183 Spec No 2: p. 26-8. |
|
Roach, M., 3rd, Editorial Comment on: High Provider Volume
is Associated with Lower Rate of Secondary Therapies after
Definitive Radiotherapy for Localized Prostate Cancer. Eur
Urol, 2007. |
|
Roach, M., 3rd, Regarding the influence of adjuvant suppression
therapy for prostate cancer on the frequency and timing of
fatal myocardial infarction: how real is the risk? J Clin
Oncol, 2007. 25(33): p. 5325-6; author reply 5326. |
|
Roach, M., 3rd, M. De Silvio, T. Rebbick,
D. Grignon, M. Rotman, H. Wolkov, B. Fisher, G. Hanks, W.U.
Shipley, A. Pollack, H. Sandler, and D. Watkins-Bruner, Racial
Differences in CYP3A4 Genotype and Survival Among Men Treated
on Radiation Therapy Oncology Group (RTOG) 9202: A Phase
III Randomized Trial. Int J Radiat Oncol Biol Phys, 2007. |
|
Roach, M., 3rd and A. Izaguirre, Goserelin
acetate in combination with radiotherapy for prostate cancer.
Expert Opin Pharmacother, 2007. 8(2): p. 257-64. |
|
Roach, M., 3rd, V. Weinberg, H. Sandler,
and I. Thompson, Staging for prostate cancer: time to incorporate
pretreatment prostate-specific antigen and Gleason score?
Cancer, 2007. 109(2): p. 213-20. |
|
Sahgal, A. and M. Roach, 3rd, Permanent
prostate seed brachytherapy: a current perspective on the
evolution of the technique and its application. Nat Clin
Pract Urol, 2007. 4(12): p. 658-70. |
|
Schiffner, D.C., A.R. Gottschalk, M. Lometti,
M. Aubin, J. Pouliot, J. Speight, I.C. Hsu, K. Shinohara,
and M. Roach, 3rd, Daily electronic portal imaging of implanted
gold seed fiducials in patients undergoing radiotherapy after
radical prostatectomy. Int J Radiat Oncol Biol Phys, 2007.
67(2): p. 610-9. |
|
Speight, J.L. and M. Roach, 3rd, Advances
in the treatment of localized prostate cancer: the role of
anatomic and functional imaging in men managed with radiotherapy.
J Clin Oncol, 2007. 25(8): p. 987-95. |
|
Speight, J.L. and M. Roach, Radiotherapy of Urologic
Tumors, in Smith’s General Urology, J. McAnnich and E. Tanagho,
Editors. 2007, Lange Medical Books/McGraw-Hill. |
|
Stone, N.N., L. Potters, B.J. Davis, J.P. Ciezki, M.J.
Zelefsky, M. Roach, P.A. Fearn, M.W. Kattan, and R.G. Stock,
Customized dose prescription for permanent prostate brachytherapy:
insights from a multicenter analysis of dosimetry outcomes.
Int J Radiat Oncol Biol Phys, 2007. 69(5): p. 1472-7. |
|
Zapotoczna, A., G. Sasso, J. Simpson, and M. Roach, 3rd,
Current role and future perspectives of magnetic resonance
spectroscopy in radiation oncology for prostate cancer. Neoplasia,
2007. 9(6): p. 455-63. |
| |
return
to top
|
|
|
|
|
|
